Enjoy complimentary customisation on priority with our Enterprise License!
The oligonucleotide therapeutics market size has the potential to grow by USD 901.18 million during 2020-2024, and the market's growth momentum will accelerate during the forecast period. The increasing incidence of cancer and increased availability of approved drugs are few of the critical oligonucleotide therapeutics market drivers and trends fueling the growth of the market.
This report provides a detailed analysis of the market by application (neurological disorder, cancer, and others), technology (Antisense/RNAi oligonucleotides, and others), and geography (APAC, Europe, MEA, North America, and South America).
An in-depth scenario-based approach was followed in this oligonucleotide therapeutics market research report to identify the direct and indirect impact of COVID-19 on market growth. Buy the full market research report to gain actionable insights on the impact of COVID-19 on oligonucleotide therapeutics market segments.
Browse TOC and LoE with selected illustrations and example pages of Oligonucleotide Therapeutics Market
The growing incidence of cancer that leads to a rise in demand for novel diagnostics will be one of the major factors driving the market growth. Several factors, such as increased pollution and adoption of a sedentary lifestyle, cause diseases such as cancer, CVD, diabetes, and autoimmune diseases. The rate of cancer has increased drastically in the last few years, and the need for novel therapeutics has increased simultaneously. Oligonucleotide therapeutics are gaining traction as it can produce a new class of nucleic acid probes known as aptamers, which are better probes than monoclonal antibodies.
The need for personalized medicines for neurodegenerative disorders, one of the oligonucleotide therapeutics market trends, will also influence the growth of the market in focus. The aged population has an increased risk for degenerated nerves, which deteriorate with time. Alzheimer's disease is one of the most common neurodegenerative disorders. Thus, the growth in aged population results in an increase in the number of individuals with Alzheimer's disease, and limitations in conventional medicines have increased research on alternative techniques such as oligonucleotide therapeutics for Alzheimer's disease. For instance, the anti-tau compound LMTX is considered to have the potential to improve cognitive abilities in individuals with Alzheimer's disease. The administration of this molecule in mice produced a form of the tau protein that acted as a tau protein aggregation inhibitor, thereby delaying the progression of Alzheimer's disease in mice. Such experiments provide useful insights into the viability of oligonucleotide therapies to treat Alzheimer's disease, thus driving the market for oligonucleotide therapeutics. Such factors will drive market growth at a CAGR of over 9%.
Request for a FREE sample and Get more information on the market contribution of various segments
Neurological disorders is the largest application segment in the oligonucleotide therapeutics market. The increase in the elderly population and the R&D investment by several vendors to develop therapeutics for neurological disorders will drive the growth of the market.
Market growth in this segment will be slower than the growth of the market in cancer and others' segment. Request for a FREE SAMPLE to get an accurate prediction of the contribution of all the segments to the growth of the oligonucleotide therapeutics market size.
For more insights on the market share of various regions Request for a FREE sample now!
Europe will offer several growth opportunities to market vendors during the forecast period. The increasing approval of products will significantly influence the growth of the oligonucleotide therapeutics market share of this region. 31% of the market's growth will originate from Europe during the forecast period. The UK and Germany are the key markets for oligonucleotide therapeutics in Europe. Market growth in this region will be slower than the growth of the market in APAC.
The oligonucleotide therapeutics market analysis report provides information on the production, sustainability, and prospects of several leading companies, including:
The market is fragmented because of the presence of a large number of vendors. This oligonucleotide therapeutics industry analysis report will help clients identify new growth opportunities and design new growth strategies. Also, this report offers a competitive analysis of the players in the antisense oligonucleotides market along with information on the products offered by the companies.
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Market Segmentation by Technology
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Certified ISO 9001 : 2015
We are ISO 9001:2015 recognized that ensures quality services and product delivery to our clients.
We are GDPR and CCPA compliant! Your transaction & personal information is protected from unauthorized use.
Get lifetime access to our
Technavio Insights
Customized Report as per your Business Needs
Let us help you make report more suited to your requirements.
Get the report (PDF) sent to your email within minutes.
